在糖尿病微血管病症中增加β-血小球蛋白水平和循环血小板聚合物
Lancet (London, England)
|February 4, 1978
概括
糖尿病微血管病症与增加的β-血小板球蛋白 (血小板蛋白) 和血小板激活有关. 在糖尿病患者中改善的血糖控制显著降低了β-血球蛋白水平.
科学领域:
- 生物化学 生物化学
- 血液学 血液学 血液学
- 内分泌学 在内分泌学.
背景情况:
- 糖尿病微血管病是糖尿病的常见并发症.
- 血小板激活在微血管疾病的发病过程中发挥着潜在的作用.
研究的目的:
- 调查β-血小球蛋白水平,血小板聚合和糖尿病微血管病变之间的关系.
- 评估血糖控制对这些标记物的影响.
主要方法:
- 从健康对照组和糖尿病患者 (有或没有微血管病变) 收集血液样本.
- 测量包括β-血球蛋白水平和血小板总量比率.
- 监测了新治疗的糖尿病患者的变化,他们改善了血糖控制.
主要成果:
- 患有微血管病的糖尿病患者表现出明显升高的β-血球蛋白水平.
- 在这些患者中也观察到可逆的血小板总量.
- 在9名新治疗的糖尿病患者中,改善了血糖控制,导致血β-血球蛋白显著下降.
结论:
- 糖尿病微血管病变与血小板激活的证据有关.
- 血小板特异性蛋白质β-血小板蛋白可能作为这种激活的标记物.
- 生物化学控制的程度似乎影响了糖尿病患者的血小板激活.
相关概念视频
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...


